Prevalence of Sarcopenia in Geriatric Patients

November 28, 2019 updated by: University Department of Geriatric Medicine FELIX PLATTER

Prevalence of Sarcopenia in Patients Admitted to a Swiss University Department of Geriatric Medicine

To assess the prevalence of sarcopenia among inpatients on acute geriatrics and geriatric rehabilitation wards of a Swiss university department of geriatric medicine using the most recent diagnosis definitions from european guidelines.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

350

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Switzerland
      • Basel, Switzerland
        • University Department of Geriatric Medicine FELIX PLATTER

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study population will be selected by the University Department of Geriatric Medicine FELIX PLATTER

Description

Inclusion Criteria:

- All patients >65 years old admitted to acute geriatrics and geriatric rehabilitation at the study site

Exclusion Criteria:

  • Lack of informed written consent
  • Implanted defibrillation device
  • Acute Sepsis, severe volume overload or dehydration
  • Life expectancy of < 3 months according to treating physician
  • Unremovable bandages
  • Patients in isolation rooms on the ward
  • Measurement is not possible due to organizational reasons
  • Inability to follow the procedures, e.g. due to language problems, psychological disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence of Sarcopenia (yes/no)
Time Frame: Baseline
Using EWGSOP2 cut-off points
Baseline
Muscle quantity, measured by Body Impedance Analysis (kg)
Time Frame: Baseline
Baseline
Hand Grip Strength (kPa)
Time Frame: Baseline
Baseline
Gait Speed (m/s)
Time Frame: Baseline
Baseline
Timed up and go Test (s)
Time Frame: Baseline
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mini Mental Status (Score range from 0 to 30 Points; higher scores reflect better cognitive status)
Time Frame: Baseline
Baseline
Nutritional risk Screening (Score range from 0 to 7 Points; higher scores reflect higher risk of malnutrition)
Time Frame: Baseline
Baseline
Geriatric Depression Scale short version (Score range from 0 to 6 Points; higher scores reflect higher risk of depression)
Time Frame: Baseline
Baseline
Functional Independence Measure at Admission (Score range from 18 to 126 Points; higher scores reflect better functionality)
Time Frame: Baseline
Baseline
Calf and Mid-upper arm Circumference (cm)
Time Frame: Baseline
Baseline
Body Mass Index (kg/m^2)
Time Frame: Baseline
Weight and height will be combined to report Body Mass Index in kg/m^2
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Department of Geriatric Medicine FELIX PLATTER

Investigators

  • Principal Investigator: Dominic K. Bertschi, Dr., University Department of Geriatric Medicine FELIX PLATTER
  • Study Chair: Caroline Kiss, Dr., University Department of Geriatric Medicine FELIX PLATTER
  • Study Director: Reto W. Kressig, Prof. Dr., University Department of Geriatric Medicine FELIX PLATTER

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 10, 2019

Primary Completion (ACTUAL)

October 30, 2019

Study Completion (ACTUAL)

October 30, 2019

Study Registration Dates

First Submitted

October 7, 2019

First Submitted That Met QC Criteria

October 10, 2019

First Posted (ACTUAL)

October 11, 2019

Study Record Updates

Last Update Posted (ACTUAL)

December 2, 2019

Last Update Submitted That Met QC Criteria

November 28, 2019

Last Verified

November 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BASEC 2019-01461

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcopenia

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe